• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国武汉 COVID-19 疫情早期确诊病例与临床诊断病例的流行病学特征比较。

The comparison of epidemiological characteristics between confirmed and clinically diagnosed cases with COVID-19 during the early epidemic in Wuhan, China.

机构信息

Department of Epidemiology and Biostatistics, School of Health Sciences, Wuhan University, 430071, Wuhan, China.

NHC Key lab of Radiation Biology, Jilin University, 130021, Changchun, China.

出版信息

Glob Health Res Policy. 2021 May 28;6(1):18. doi: 10.1186/s41256-021-00200-8.

DOI:10.1186/s41256-021-00200-8
PMID:34049599
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8161348/
Abstract

BACKGROUND

To put COVID-19 patients into hospital timely, the clinical diagnosis had been implemented in Wuhan in the early epidemic. Here we compared the epidemiological characteristics of laboratory-confirmed and clinically diagnosed cases with COVID-19 in Wuhan.

METHODS

Demographics, case severity and outcomes of 29,886 confirmed cases and 21,960 clinically diagnosed cases reported between December 2019 and February 24, 2020, were compared. The risk factors were estimated, and the effective reproduction number (Rt) of SARS-CoV-2 was also calculated.

RESULTS

The age and occupation distribution of confirmed cases and clinically diagnosed cases were consistent, and their sex ratio were 1.0 and 0.9, respectively. The epidemic curve of clinical diagnosis cases was similar to that of confirmed cases, and the city centers had more cumulative cases and higher incidence density than suburbs in both of two groups. The proportion of severe and critical cases (21.5 % vs. 14.0 %, P < 0.0001) and case fatality rates (5.2 % vs. 1.2 %, P < 0.0001) of confirmed cases were all higher than those of clinically diagnosed cases. Risk factors for death we observed in both of two groups were older age, male, severe or critical cases. Rt showed the same trend in two groups, it dropped below 1.0 on February 6 among confirmed cases, and February 8 among clinically diagnosed cases.

CONCLUSIONS

The demographic characteristics and spatiotemporal distributions of confirmed and clinically diagnosed cases are roughly similar, but the disease severity and clinical outcome of clinically diagnosed cases are better than those of confirmed cases. In cases when detection kits are insufficient during the early epidemic, the implementation of clinical diagnosis is necessary and effective.

摘要

背景

为了及时收治 COVID-19 患者,武汉在疫情早期就实施了临床诊断。本研究比较了武汉确诊病例和临床诊断病例的流行病学特征。

方法

比较了 2019 年 12 月至 2020 年 2 月 24 日报告的 29886 例确诊病例和 21960 例临床诊断病例的人口统计学特征、病例严重程度和结局。估计了危险因素,并计算了 SARS-CoV-2 的有效繁殖数(Rt)。

结果

确诊病例和临床诊断病例的年龄和职业分布一致,男女比例分别为 1.0 和 0.9。临床诊断病例的流行曲线与确诊病例相似,市中心的累计病例数和发病率密度均高于郊区。确诊病例的重症和危重症比例(21.5%比 14.0%,P<0.0001)和病死率(5.2%比 1.2%,P<0.0001)均高于临床诊断病例。两组中观察到的死亡危险因素均为年龄较大、男性、重症或危重症病例。Rt 在两组中呈相同趋势,确诊病例于 2 月 6 日降至 1.0 以下,临床诊断病例于 2 月 8 日降至 1.0 以下。

结论

确诊病例和临床诊断病例的人口统计学特征和时空分布大致相似,但临床诊断病例的疾病严重程度和临床结局优于确诊病例。在疫情早期检测试剂盒不足的情况下,实施临床诊断是必要且有效的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70e6/8161939/11743903dc15/41256_2021_200_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70e6/8161939/4fc79c03f722/41256_2021_200_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70e6/8161939/20a4894c003c/41256_2021_200_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70e6/8161939/5d2eae8e690e/41256_2021_200_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70e6/8161939/11743903dc15/41256_2021_200_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70e6/8161939/4fc79c03f722/41256_2021_200_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70e6/8161939/20a4894c003c/41256_2021_200_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70e6/8161939/5d2eae8e690e/41256_2021_200_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70e6/8161939/11743903dc15/41256_2021_200_Fig4_HTML.jpg

相似文献

1
The comparison of epidemiological characteristics between confirmed and clinically diagnosed cases with COVID-19 during the early epidemic in Wuhan, China.中国武汉 COVID-19 疫情早期确诊病例与临床诊断病例的流行病学特征比较。
Glob Health Res Policy. 2021 May 28;6(1):18. doi: 10.1186/s41256-021-00200-8.
2
Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China.公共卫生干预措施与中国武汉 COVID-19 疫情流行病学的关联。
JAMA. 2020 May 19;323(19):1915-1923. doi: 10.1001/jama.2020.6130.
3
[Epidemiological characteristics of COVID-19 in Wuchang district of Wuhan].[武汉武昌区新型冠状病毒肺炎的流行病学特征]
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Oct 10;41(10):1616-1622. doi: 10.3760/cma.j.cn112338-20200412-00565.
4
Epidemiology of COVID-19 in older persons, Wuhan, China.中国武汉老年人中 COVID-19 的流行病学。
Age Ageing. 2020 Aug 24;49(5):706-712. doi: 10.1093/ageing/afaa145.
5
Epidemiological and clinical characteristics analysis of COVID-19 in the surrounding areas of Wuhan, Hubei Province in 2020.2020 年湖北省武汉市周边地区 COVID-19 的流行病学和临床特征分析。
Pharmacol Res. 2020 Jul;157:104821. doi: 10.1016/j.phrs.2020.104821. Epub 2020 Apr 30.
6
Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study.中国湖北省以外地区 2019 年冠状病毒病的流行病学和传播动态演变:描述性和建模研究。
Lancet Infect Dis. 2020 Jul;20(7):793-802. doi: 10.1016/S1473-3099(20)30230-9. Epub 2020 Apr 2.
7
Early epidemiological assessment of the transmission potential and virulence of coronavirus disease 2019 (COVID-19) in Wuhan City, China, January-February, 2020.2020 年 1 月至 2 月中国武汉市 2019 年冠状病毒病(COVID-19)传播潜力和毒力的早期流行病学评估。
BMC Med. 2020 Jul 15;18(1):217. doi: 10.1186/s12916-020-01691-x.
8
Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study.家庭传播 SARS-CoV-2 及武汉地区易感性和传染性的危险因素:一项回顾性观察研究。
Lancet Infect Dis. 2021 May;21(5):617-628. doi: 10.1016/S1473-3099(20)30981-6. Epub 2021 Jan 18.
9
Ecological Study on Differences in COVID-19 Fatality among Wuhan, Rest of Hubei, and Rest of China.武汉、湖北省其他地区和中国其他地区 COVID-19 病死率差异的生态学研究。
J Epidemiol Glob Health. 2021 Mar;11(1):42-45. doi: 10.2991/jegh.k.200902.001. Epub 2020 Sep 10.
10
Epidemiological characteristics of COVID-19 cases and estimates of the reproductive numbers 1 month into the epidemic, Italy, 28 January to 31 March 2020.2020 年 1 月 28 日至 3 月 31 日意大利新冠疫情流行 1 个月时的病例流行病学特征及繁殖数估计
Euro Surveill. 2020 Dec;25(49). doi: 10.2807/1560-7917.ES.2020.25.49.2000790.

引用本文的文献

1
Using the SEIQR model with epidemic amplifier effect to predict the final outbreak size of the COVID-19 in Dalian, Liaoning province, China.运用具有疫情放大效应的SEIQR模型预测中国辽宁省大连市新冠疫情的最终爆发规模。
PLoS One. 2024 Dec 12;19(12):e0307239. doi: 10.1371/journal.pone.0307239. eCollection 2024.
2
Medical implementation practice and its medical performance evaluation of a giant makeshift hospital during the COVID-19 pandemic: An innovative model response to a public health emergency in Shanghai, China.在 COVID-19 大流行期间,一座大型临时医院的医疗实施实践及其医疗效果评价:中国上海应对公共卫生突发事件的创新性模式反应。
Front Public Health. 2023 Jan 6;10:1019073. doi: 10.3389/fpubh.2022.1019073. eCollection 2022.
3

本文引用的文献

1
The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020.2019新型冠状病毒病(COVID-19)疫情的流行病学特征 - 中国,2020年
China CDC Wkly. 2020 Feb 21;2(8):113-122.
2
The epidemiological characteristics of deaths with COVID-19 in the early stage of epidemic in Wuhan, China.中国武汉 COVID-19 疫情早期死亡病例的流行病学特征。
Glob Health Res Policy. 2020 Dec 21;5(1):54. doi: 10.1186/s41256-020-00183-y.
3
Epidemiological characteristics of patients with severe COVID-19 infection in Wuhan, China: evidence from a retrospective observational study.
Emergency Preparedness and Management of Mobile Cabin Hospitals in China During the COVID-19 Pandemic.中国在 COVID-19 大流行期间的移动方舱医院的应急准备和管理。
Front Public Health. 2022 Jan 3;9:763723. doi: 10.3389/fpubh.2021.763723. eCollection 2021.
4
Risk factors for poor prognosis in children and adolescents with COVID-19: A systematic review and meta-analysis.新冠病毒病儿童及青少年预后不良的危险因素:一项系统评价与Meta分析
EClinicalMedicine. 2021 Nov;41:101155. doi: 10.1016/j.eclinm.2021.101155. Epub 2021 Oct 19.
中国武汉严重 COVID-19 感染患者的流行病学特征:一项回顾性观察研究的证据。
Int J Epidemiol. 2021 Jan 23;49(6):1940-1950. doi: 10.1093/ije/dyaa180.
4
Aging in COVID-19: Vulnerability, immunity and intervention.COVID-19 相关衰老问题:脆弱性、免疫与干预。
Ageing Res Rev. 2021 Jan;65:101205. doi: 10.1016/j.arr.2020.101205. Epub 2020 Oct 31.
5
Considering how biological sex impacts immune responses and COVID-19 outcomes.考虑到生物性别如何影响免疫反应和 COVID-19 的结果。
Nat Rev Immunol. 2020 Jul;20(7):442-447. doi: 10.1038/s41577-020-0348-8. Epub 2020 Jun 11.
6
Influence of population mobility on the novel coronavirus disease (COVID-19) epidemic: based on panel data from Hubei, China.人口流动对新型冠状病毒病(COVID-19)疫情的影响:基于中国湖北省的面板数据。
Glob Health Res Policy. 2020 Jun 8;5:30. doi: 10.1186/s41256-020-00151-6. eCollection 2020.
7
Impact of sex and gender on COVID-19 outcomes in Europe.欧洲 COVID-19 结局的性别差异。
Biol Sex Differ. 2020 May 25;11(1):29. doi: 10.1186/s13293-020-00304-9.
8
Effect of changing case definitions for COVID-19 on the epidemic curve and transmission parameters in mainland China: a modelling study.中国大陆调整 COVID-19 病例定义对疫情曲线和传播参数的影响:一项建模研究。
Lancet Public Health. 2020 May;5(5):e289-e296. doi: 10.1016/S2468-2667(20)30089-X. Epub 2020 Apr 21.
9
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan.武汉成人 COVID-19 住院患者严重程度和死亡率的危险因素。
J Allergy Clin Immunol. 2020 Jul;146(1):110-118. doi: 10.1016/j.jaci.2020.04.006. Epub 2020 Apr 12.
10
Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China.公共卫生干预措施与中国武汉 COVID-19 疫情流行病学的关联。
JAMA. 2020 May 19;323(19):1915-1923. doi: 10.1001/jama.2020.6130.